Systemic quinolones and risk of acute liver failure I: Analysis of data from the US FDA adverse event reporting system

6Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background and Aim: Quinolones are a potent and globally popular group of antibiotics that are used to treat a wide range of infections. Some case reports have raised concern about their possible association with acute hepatic failure (AHF). Data from the US FDA Adverse Event Reporting System were evaluated for signals of AHF in association with systemically administered quinolone antibiotics. Methods: AHF reports between 1969 and 2019q2, with a focus on 2010–2019q2, were analyzed. Specifically, AHF reports linked to non-quinolone antibiotics of known hepatotoxicity were compared to reports with non-quinolone, non-hepatotoxic (reference) antibiotics; and AHF reports with quinolones were also compared to reports with the same group of reference antibiotics. Two disproportionality signal detection techniques (proportional reporting ratio, PRR, and empirical Bayes geometric mean, EBGM) were used to assess the AHF signal for both analyses. Results: Only ciprofloxacin showed a marginal and significant AHF signal (PRR: 1.85 [1.21, 2.81]; EBGM: 1.54 [1.06, 1.81]); moxifloxacin, levofloxacin, and ofloxacin showed weak and nonsignificant signals. Conclusion: Further pharmacovigilance studies are required to confirm the association between ciprofloxacin and AHF seen in the present analysis.

References Powered by Scopus

Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States

763Citations
N/AReaders
Get full text

Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of iceland

718Citations
N/AReaders
Get full text

Drug-induced liver injury

349Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Overview of Side-Effects of Antibacterial Fluoroquinolones: New Drugs versus Old Drugs, a Step Forward in the Safety Profile?

56Citations
N/AReaders
Get full text

Safety of fluoroquinolones

2Citations
N/AReaders
Get full text

Pay attention to the study of risk factors related to adverse reactions of anti-bacterial agents

1Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Taher, M. K., Alami, A., Gravel, C. A., Tsui, D., Bjerre, L. M., Momoli, F., … Krewski, D. (2021). Systemic quinolones and risk of acute liver failure I: Analysis of data from the US FDA adverse event reporting system. JGH Open, 5(7), 778–784. https://doi.org/10.1002/jgh3.12585

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 1

100%

Save time finding and organizing research with Mendeley

Sign up for free